| Literature DB >> 31049001 |
Naif Abdullah Al-Dhabi1, Galal Ali Esmail1, Veeramuthu Duraipandiyan1, Mariadhas Valan Arasu1.
Abstract
Filamentous bacterial belonged to Streptomyces species were novel drug source for medical and industrial applications. However, the detailed identification of Streptomyces species from Saudi Arabian extreme environment for the identification novel drug source for medical and industrial applications were rarely studied. The Streptomyces strain Al-Dhabi-2 obtained from the thermophilic region kingdom of Saudi Arabia, exhibited antimicrobial potentials against the pathogenic microorganism were characterized. Biochemical and phylogenetic analysis confirmed that the strain was closely associated to the Streptomyces species. The chromatogram of GC-MS analysis of this ethyl acetate extract (EA) had diverse of chemical compounds namely benzene acetic acid (7.81%), acetic acid, methoxy-, 2-phenylethyl ester (6.01%) were the major compounds. EA of Al-Dhabi-2 showed inhibition zone ranged from 14 to 25 mm at 5 mg/well concentration against the tested microbial pathogens. Results revealed that the significant MIC values were observed against B. cereus, and E. faecalis by (less than 39 μg/ml) and against S. agalactiae with (78 μg/ml). Minimum inhibitory concentrations (MIC) for fungi: were also reported against Cryptococcus neoformans and Trichophyton mentagrophytes by (156 μg/ml), whilst Candida albicans and Aspergillus niger by (312 μg/ml). Results of this study showed that thermophilic actinobacteria could be promise source in the context of searching for unique antimicrobial agents with novel properties.Entities:
Keywords: 16S rRNA gene; Antimicrobial activity; GC-MS; Hot spring; Thermophilic Streptomyces
Year: 2019 PMID: 31049001 PMCID: PMC6486537 DOI: 10.1016/j.sjbs.2019.03.009
Source DB: PubMed Journal: Saudi J Biol Sci ISSN: 1319-562X Impact factor: 4.219
Fig. 1Hot spring of Saudi Arabia, taken from Google earth.
Morphological traits of the strain Al-Dhabi-2.
| Media | Growth | Colour of aerial mycelium | Reverse side colour | Pigment |
|---|---|---|---|---|
| MNGA | +++ | Grey | Yellow-brown | Absent |
| ISP-2 | ++ | Grey | Yellow-brown | Absent |
| ISP-3 | ++ | Grey | Brown | Absent |
| ISP-4 | ++ | Grey | White | Absent |
| ISP-5 | +++ | Whitesh-grey | White | Absent |
+++: prolific growth and ++: good growth.
Biochemical and physiological traits of the strain Al-Dhabi-2.
| Characteristics | Results |
|---|---|
| Gram stain | Positive |
| Growth | Filamentous aerial growth |
| diffusible pigment production | – |
| Melanoid production | – |
| Growth temperature range | 29 °C to 55 °C |
| Growth optimal temperature | 50 °C |
| Growth pH range | 5–9 |
| Optimal pH for growth | 7.0 |
| Production of H2S | − |
| Amylase | + |
| Protease | − |
| Gelatinase | + |
| deoxyribonuclease (DNase) production | + |
| NaCl tolerant | 4% to 7% |
| Negative control; none carbon source | − |
| Positive control; glucose | ++ |
| Sucrose | − |
| D-fructose | + |
| D-rhamnose | ++ |
| D-Xylose | ++ |
| D-arabinose | ++ |
| D-manitol | ++ |
| Ciprofloxacin (5 µg) | S |
| Gentamicin (10 µg) | S |
| Penicillin (10 µg) | R |
| Chloramphenicol (30 µg) | S |
| Vancomycin (30 µg) | S |
| Tetracycline (30 µg) | S |
| Nystatin (100 µg) | R |
+: presence; −: absence; S: Sensitive; R: Resistance.
Fig. 2Neighbour-joining tree based on partial 16S rRNA gene sequences showing the relationship between strain Al-Dhabi-2 and 22 species of the genus Streptomyces. Values at nodes point to bootstrap support (%) levels based on analysis of 1000 resampled datasets the values >50% are given only. Numbers between parentheses are NCBI accession numbers for each sequence.
Antimicrobial activity of Al-Dhabi-2 in preliminary screening.
| Tested microbes | ATCC* strain No. | Inhibition activity |
|---|---|---|
| 11778 | ++ | |
| 12228 | ++ | |
| 6538P | + | |
| 49532 | +++ | |
| 27956 | ++ | |
| 10536 | ++ | |
| 33420 | + | |
| 27853 | ++ | |
| 13311 | ++ | |
| 13882 | ++ | |
| 2091 | ++ | |
| Clinical strain | ++ |
ATCC: American type culture collection, +: moderate; ++: good; +++: Significant.
The activity of Al-Dhabi-2 ethyl acetate extract against list of human pathogens.
| Microorganisms | ATCC No. | Zone of inhibition in mm | |
|---|---|---|---|
| Bacteria | Al-Dhabi-2 (5 mg/well) | Streptomycin 10 µg | |
| 11778 | 15 | 22 | |
| 12228 | 15 | – | |
| 6538P | 11 | 12 | |
| 49532 | 16 | 24 | |
| 27956 | 15 | 20 | |
| 10536 | 14 | 15 | |
| 33420 | 10 | 15 | |
| 27853 | 14 | 16 | |
| 13311 | 10 | 17 | |
| 13882 | 11 | 17 | |
| 16888 | 19 | 27 | |
| 9533 | 16 | – | |
| 2091 | 10 | 22 | |
| Clinical strain | 10 | – | |
–: no activity.
Fig. 3Antimicrobial activity of Al-Dhabi-1 ethyl acetate extract against human pathogenic microbes. (A) E. faecalis; (B) S. agalactiae; (C) A. niger and (D) A. niger (reverse side of the plate). PC; positive control and NC; negative control.
MIC values of Al-Dhabi-2 ethyl acetate extract using micro-broth dilution method.
| Microorganisms | ATCC No. | MIC | |
|---|---|---|---|
| Bacteria | Al-Dhabi-2 (mg/ml) | Streptomycin µg/ml | |
| 11778 | <0.039 | 0.156 | |
| 12228 | 0.156 | >10 | |
| 6538P | 0.625 | 2.5 | |
| 49532 | <0.039 | 1.25 | |
| 27956 | 0.078 | 1.25 | |
| 10536 | 0.312 | 0.625 | |
| 33420 | 0.625 | 5 | |
| 27853 | 0.625 | 1.25 | |
| 13311 | 0.312 | 5 | |
| 13882 | 0.156 | 0.625 | |
| 16888 | 0.312 | 62.5 | |
| 9533 | 0.156 | >500 | |
| 2091 | 0.312 | <4 | |
| Clinical strain | 0.156 | 250 | |
Chemical profile of ethyl acetate extract.
| Sl. no | RT | Compound | Quality | Molecular weight | Peak area % |
|---|---|---|---|---|---|
| 1 | 4.059 | Diisopropyl ether | 45 | 102.104 | 5.25 |
| 2 | 5.700 | Hexylene glycol | 59 | 118.099 | 3.06 |
| 3 | 8.082 | Phenylethyl Alcohol | 94 | 122.073 | 2.59 |
| 4 | 9.084 | Benzoic acid | 53 | 122.037 | 3.00 |
| 5 | 10.463 | Acetic acid, 2-phenylethyl ester | 90 | 164.084 | 10.45 |
| 6 | 10.594 | Benzene acetic acid | 94 | 136.052 | 7.81 |
| 7 | 12.526 | 1-Tetradecene | 99 | 196.219 | 0.85 |
| 8 | 13.136 | Trans-Cinnamic acid | 96 | 148.052 | 1.95 |
| 9 | 13.557 | Acetic acid, methoxy-, 2-phenylethyl ester | 83 | 194.094 | 6.01 |
| 10 | 14.878 | N-Acetyltyramine | 50 | 179.095 | 0.95 |
| 11 | 15.241 | Cetene | 99 | 224.25 | 2.41 |
| 12 | 16.853 | 7-Acetyl-1,7-diazabicyclo[2.2.0]he ptane | 22 | 140.095 | 1.26 |
| 13 | 17.652 | 1-Octadecene | 99 | 252.282 | 2.26 |
| 14 | 17.783 | Coumarin | 58 | 146.037 | 0.88 |
| 15 | 18.044 | Phenol, 3,5-dimethoxy- | 49 | 154.063 | 2.94 |
| 16 | 18.262 | N-Acetyltyramine | 91 | 179.095 | 1.85 |
| 17 | 19.105 | l-Proline, N-allyloxycarbonyl-, heptyl ester | 43 | 297.194 | 3.32 |
| 18 | 19.293 | Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-3-(2-methylpropyl)- | 95 | 210.137 | 5.45 |
| 19 | 19.831 | E-15-Heptadecenal | 99 | 252.245 | 1.46 |
| 20 | 21.573 | 2,5-Piperazinedione, 3-methyl-6-(p henylmethyl)- | 95 | 218.106 | 1.01 |
| 21 | 21.733 | 2,5-Piperazinedione, 3,6-bis(2-met hylpropyl)- | 43 | 266.168 | 6.62 |
| 22 | 21.820 | 1-Docosene | 97 | 308.344 | 1.11 |
| 23 | 22.227 | 2-(3-Amino-1,2,4-triazol-2-yl)(4,5H)imidazoline | 35 | 152.081 | 0.64 |
| 24 | 23.331 | Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-3-(phenylmethyl)- | 91 | 244.121 | 2.64 |
| 25 | 23.389 | 9-Octadecenamide, (Z)- | 99 | 281.272 | 2.44 |
| 26 | 25.422 | Fumaric acid, propyl 2,3,6-trichlo rophenyl ester | 35 | 335.972 | 1.63 |
| 27 | 25.800 | Formamide, N-(2,4-diamino-1,6-dihy dro-6-oxo-5-pyrimidinyl)- | 37 | 169.06 | 3.13 |
| 28 | 26.264 | Bicyclo[3.1.1]heptan-2-one, 6,6-di methyl-, (1R)- | 55 | 138.104 | 1.49 |
| 29 | 26.511 | Tartaric acid, dimenthyl ester | 64 | 426.298 | 2.60 |
| 30 | 27.150 | Squalene | 99 | 410.39 | 0.63 |
Fig. 4Chemical structure of major compounds of Al-Dhabi-2 crude extract.